Filing Flows › Idexx Laboratories (IDXX) › Who owns the stock
Who owns Idexx Laboratories (IDXX) stock
1,236 funds reported Idexx Laboratories (IDXX) shares in their latest 13F filings, worth $44.5B in all. The largest holder is Vanguard Group ($6.7B). Last quarter 519 funds added to their stakes and 562 cut them. Members of Congress and other officials disclosed 1 trade (0 buys, 1 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 9,945,328 | $6.7B | decrease | 2025-12-31 |
| BlackRock | 8,170,178 | $4.3B | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 5,152,213 | $2.7B | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3,896,521 | $2.1B | decrease | 2026-06-30 |
| State Street | 3,748,660 | $2.0B | increase | 2026-06-30 |
| Invesco | 3,611,416 | $1.9B | increase | 2026-06-30 |
| Geode Capital Management, LLC | 2,562,886 | $1.3B | decrease | 2026-06-30 |
| Bamco | 1,976,778 | $1.0B | increase | 2026-06-30 |
| Morgan Stanley | 1,356,103 | $714M | increase | 2026-06-30 |
| Bank of New York Mellon | 1,193,343 | $628M | decrease | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 1,067,078 | $562M | increase | 2026-06-30 |
| Fundsmith LLP | 1,019,887 | $537M | decrease | 2026-06-30 |
| Blair William | 918,556 | $484M | decrease | 2026-06-30 |
| Northern Trust | 918,137 | $483M | increase | 2026-06-30 |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | 911,489 | $480M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-01-13 | April McClain Delaney | sale | $1K–$15K |
Idexx Laboratories' latest quarter
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most IDXX stock?
By the latest 13F filings: Vanguard Group ($6.7B); BlackRock ($4.3B); Vanguard Capital Management LLC ($2.7B); Vanguard Portfolio Management LLC ($2.1B); State Street ($2.0B).
Has Congress traded IDXX stock?
Officials disclosed 1 trade on file: 0 buys and 1 sales. The latest: April McClain Delaney, sale on 2026-01-13.
What is the short interest in IDXX?
1,929,268 shares were sold short at the 2026-10-15 settlement, -0.59% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.